$1.07 Billion in Sales Expected for Encompass Health Corp (NYSE:EHC) This Quarter

Wall Street brokerages expect that Encompass Health Corp (NYSE:EHC) will report $1.07 billion in sales for the current quarter, Zacks reports. Seven analysts have provided estimates for Encompass Health’s earnings, with estimates ranging from $1.00 billion to $1.17 billion. Encompass Health posted sales of $1.14 billion in the same quarter last year, which suggests a negative year-over-year growth rate of 6.1%. The firm is expected to issue its next quarterly earnings report after the market closes on Monday, July 27th.

According to Zacks, analysts expect that Encompass Health will report full year sales of $4.69 billion for the current fiscal year, with estimates ranging from $4.61 billion to $4.84 billion. For the next fiscal year, analysts forecast that the business will report sales of $5.20 billion, with estimates ranging from $5.10 billion to $5.26 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that follow Encompass Health.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Tuesday, April 28th. The company reported $0.87 EPS for the quarter, hitting analysts’ consensus estimates of $0.87. Encompass Health had a return on equity of 22.00% and a net margin of 7.36%. The company had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.20 billion.

A number of research analysts have commented on the company. Stephens upped their price target on Encompass Health from $91.00 to $100.00 and gave the stock an “overweight” rating in a research note on Thursday, March 5th. UBS Group decreased their price target on Encompass Health from $96.00 to $90.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Mizuho upped their price target on Encompass Health from $87.00 to $90.00 and gave the stock a “buy” rating in a research note on Thursday, March 5th. Robert W. Baird upped their price target on Encompass Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, March 5th. Finally, Deutsche Bank increased their target price on Encompass Health from $73.00 to $83.00 and gave the company a “hold” rating in a report on Friday, March 6th. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $91.78.

NYSE:EHC traded up $1.37 during trading hours on Monday, reaching $60.68. 658,484 shares of the stock were exchanged, compared to its average volume of 811,542. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 1.98. The business has a 50-day moving average of $68.94 and a two-hundred day moving average of $70.59. Encompass Health has a twelve month low of $48.01 and a twelve month high of $83.30. The company has a market capitalization of $5.90 billion, a price-to-earnings ratio of 17.31, a PEG ratio of 6.80 and a beta of 0.88.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 1.85%. The ex-dividend date is Tuesday, June 30th. Encompass Health’s dividend payout ratio (DPR) is presently 28.64%.

About Encompass Health

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Further Reading: How can investors invest in the S&P/TSX Index?

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.